outcomes research

Research in Review

Factors Affecting 30-Day Mortality in Women With Breast and Lung Cancer

09/04/2016

JCP Editors

Researchers have identified several factors that may affect the risk of early mortality among patients with breast and lung cancer, according to a recent study. In a study published in The Lancet Oncology,...

...

09/04/2016

Journal of Clinical Pathways

Research in Review

Breast Conservation Therapy at Community Settings Leads to Higher Survival Rates than the National Average

09/02/2016

JCP Editors

Breast conservation treatment may led to longer overall survival than other treatment methods for early stage breast cancer, according to a study published in The Journal of Community and Supportive Oncology....

Breast...

09/02/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of Aug 29-Sept 4

09/01/2016

JCP Editors

A study published in JAMA Oncology found that increasing the number of treatment cycles with what drug led to improved overall survival in men with metastatic castration-resistant prostate...

A...

09/01/2016

Journal of Clinical Pathways

Research in Review

Noncompliance With NCCN Guidelines Can Worsen Rectal Cancer Survival

08/31/2016

JCP Editors

Not complying with recommendations found in National Comprehensive Cancer Network (NCCN) guidelines for locally advanced rectal cancer may led to worse overall survival, according to a study published in the journal...

Not...

08/31/2016

Journal of Clinical Pathways

Research in Review

More Chemotherapy Does Not Lead to Improved Outcomes for Patients With Osteosarcoma

08/31/2016

JCP Editors

Results from a large clinical trial argue against the inclusion of ifosfamide and etoposide to postoperative chemotherapy in patients with poorly responding osteosarcoma due to increasing toxicity and no improvement...

...

08/31/2016

Journal of Clinical Pathways

Research in Review

More Docetaxel Cycles May Improve Prostate Cancer Survival

08/30/2016

JCP Editors

A larger number of docetaxel cycles may improve survival among men with metastatic castration-resistant prostate cancer (mCRPC), according to a post-hoc analysis of phase III clinical trial results. Scientists and...

A...

08/30/2016

Journal of Clinical Pathways

Research in Review

70-Gene Signature Aids Breast Cancer Decision-Making

08/30/2016

JCP Editors

The 70-gene signature test may help patients with early-stage breast cancer avoid unneeded chemotherapy, according to the results of a study published in The New England Journal of Medicine. The 70-gene signature...

The...

08/30/2016

Journal of Clinical Pathways

Research in Review

Lymph Node Metastasis Predicts Prognosis for Late-State NSCLC

08/26/2016

JCP Editors

Lymph node stage may provide important prognostic information related to survival for patients with non-small cell lung cancer (NSCLC), according to a study published in the Journal of Thoracic Oncology. Guidelines...

Lymph...

08/26/2016

Journal of Clinical Pathways

Research in Review

Genetic Variant of Rectal Cancer Predicts Prognosis, Treatment Response

07/25/2016

JCP Editors

DNA mismatch repair (dMMR) deficiency rectal cancer is associated with excellent prognosis and pathologic response with current therapeutic options and surgical procedures, according to research published in the...

DNA...

07/25/2016

Journal of Clinical Pathways

Research in Review

Surgery Improves Survival in Patients With Renal Cancer

06/21/2016

JCP Editors

Surgery may improve survival for patients who receive targeted therapies for metastatic renal cell cancer, according to a study by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital (Boston,...

...

06/21/2016

Journal of Clinical Pathways